Abstracts

REDUCTION OF HIV INCIDENCE AFTER ELIMINATION OF LYMPHATIC FILARIASIS

Background: A general population survey from 2007 to 2011 in Southwest Tanzania previously revealed a 2.3-fold increased HIV incidence among individuals infected with Wuchereria bancrofti (WB), the parasite causing lymphatic filariasis. In 2007, the prevalence of filarial and HIV infections were 36.4% (385/1058) and 13.8% (162/1173), respectively, for individuals aged 14 to 65. A government…

12-MONTH CONSEQUENCES IN PEOPLE WITH HIV/SARS-CoV-2 COINFECTION: NATIONAL EHR COHORT

Background: Background: Long-term consequences of COVID-19 are well characterized in general populations. Yet it remains unclear how existing HIV infection attributes to the risks of long-term consequences in people with coinfection of HIV/SARS-CoV-2. This study aims to examine the long-term consequences of people living with HIV (PLWH) at 12 months after the first SARS-CoV-2 infection.…

EFFICACY OF 3TC+DTG VS 3-DRUG REGIMENS IN VIROLOGICALLY-SUPPRESSED PLWH

Background: In people living with HIV (PLWH) lamivudine (3TC)+dolutegravir (DTG) maintenance dual therapy (DT) could be less effective than three-drug therapies (TT) with 2NRTIs+DTG in the context of both resistance-associated mutations (RAMs) and lower time of virological suppression (VS). However, data have shown that PLWH who switch to DT usually have longer time of VS…

CONTROLLED ATTENUATION PARAMETER IS A VISCERAL ADIPOSITY MARKER IN HIV-RELATED NAFLD

Background: Fat alterations are frequent in people with HIV (PWH) and predict worse cardiometabolic outcomes. Visceral adipose tissue (VAT) is a hormonally active tissue critically contributing to obesity-related disorders and associated with ectopic fat accumulation in the liver. We aimed to investigate HIV-associated nonalcoholic fatty liver disease (NAFLD) diagnosed by controlled attenuation parameter (CAP) as…

OLFACTORY PERFORMANCE IN POST MILD-TO-MODERATE ACUTE COVID-19 ACROSS 2 YEARS

Background: Previous longitudinal studies (n=6) of objective olfaction performance post-acute COVID-19 have a maximum follow-up of 6-month and do not often test biomarkers. Although olfactory dysfunction appears to improve within two months of symptom onset, 4/6 longitudinal studies show persistent olfactory impairment. Methods: PCR-confirmed COVID-19 patients in the prospective ADAPT cohort (Sydney, Australia) were assessed…

IMMUNE MARKERS IN PREGNANT WOMEN LIVING WITH HIV ON ART THERAPY BY MATERNAL BMI

Background: Obesity impairs immune functioning so concerns exist that elevated body mass index (BMI) in HIV+ pregnant women could lead to immune dysregulation. This disruption of pregnancy associated immune processes could increase risk of pregnancy complications. We investigated temporal trends of inflammatory biomarkers and impact of maternal BMI. Methods: We recruited a cohort of ART-eligible…

LONG NON-CODING RNA REGULATES IFN-I RESPONSE AND SARS-CoV-2 REPLICATION

Background: Infection with SARS-CoV-2 triggers reprogramming through global transcriptomic changes that drive the development of Coronavirus disease 2019 (COVID-19). Although the expression and functions of protein-coding transcripts have been widely studied in SARS-CoV-2 infection, most of the transcriptome consists of non-protein-coding RNAs (ncRNAs). Long noncoding RNAs (lncRNAs), which constitute a large proportion of the transcriptome,…